French health-tech startup Biolevate has raised €6 million in a seed funding spherical led by EQT Ventures, with participation from bpifrance, to speed up work on their AI-assisted medical writing platform.
Based in 2024, Biolevate goals to make use of AI to remodel medical writing processes, enabling quicker, extra environment friendly creation of regulatory-compliant paperwork for the healthcare and pharmaceutical industries.
Joël Belafa, Co-founder and CEO of Biolevate, highlighted the corporate’s mission: “Synthetic intelligence has immense potential, and we established Biolevate with a transparent mission of utilizing AI to speed up the event of recent therapies, guaranteeing sufferers obtain life-saving therapies quicker. With our platform, medical writing will be achieved at a a lot quicker price whereas guaranteeing accuracy of knowledge at each stage of drug discovery and improvement – in the end elevating the usual of healthcare.”
Biolevate’s proprietary platform, ELISE, leverages superior AI applied sciences, together with Pure Language Processing (NLP), Pc Imaginative and prescient, and Graph Neural Networks (GNN), to help medical writers in creating and managing in depth scientific paperwork. The platform presents real-time collaborative writing capabilities, automated regulatory validation, and instruments for conducting knowledge evaluation, reportedly lowering the time required to convey new medical merchandise to market.
In accordance with Biolevate, pharmaceutical R&D spending has doubled over the previous decade, whereas the method of making regulatory paperwork stays extremely guide and labour-intensive, compounded by a rising world scarcity of expert medical writers. Biolevate’s platform goals to deal with these challenges by streamlining documentation workflows, guaranteeing compliance with stringent requirements, and enabling researchers to give attention to innovation reasonably than administrative duties.
Julien Hobeika, Accomplice at EQT Ventures, commented: “There’s a major alternative in making medical writing extra environment friendly utilizing AI, and the staff at Biolevate presents a powerful answer to remodel medical documentation processes right into a seamless and efficient process that helps innovation and drives scientific breakthroughs benefiting society. At EQT Ventures, we assist generation-defining corporations that may convert their imaginative and prescient into world successes – and Joël and the staff are simply getting began: In the long term, their platform can increase any scientist, working with any kind of supplies.”
Biolevate plans to make use of the funding to reinforce its platform additional and develop its staff. By addressing the regulatory and operational bottlenecks within the improvement of therapies, Biolevate goals to cut back time-to-market for brand spanking new therapies, enhance healthcare accessibility, and assist world scientific innovation.
